Allergan (AGN)

198.32 -0.94 (0.47%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/7/20 *Est.)
- M&A (N/A)

Latest Headlines

Announcement under the Irish Takeover Rules: Relevant Securities in Issue - February 14, 2020 February 14, 2020 4:15 PM - PR NewsWire Appaloosa Enters New Stake in INTELSAT (I), Raises Alibaba (BABA) (more...) - 13F February 14, 2020 4:07 PM - StreetInsider Announcement under Rule 8.1(a) of the Irish Takeover Rules: Dealings by Offerors, Offerees or Parties Acting in Concert With Them for Themselves or for Discretionary Clients February 14, 2020 7:00 AM - PR NewsWire Dan Loeb's Third Point Show's New $150M Stake in Amazon (AMZN), Enters Ferrari (RACE) (more...) - 13F February 13, 2020 5:13 PM - StreetInsider Form 5 Allergan plc For: Dec 31 Filed by: COUGHLIN CHRISTOPHER J February 13, 2020 5:12 PM - SEC Filing Form SC 13G/A AEGON NV Filed by: DODGE & COX February 13, 2020 12:32 PM - SEC Filing Form 6-K AEGON NV For: Feb 13 February 13, 2020 11:55 AM - SEC Filing Algernon Pharmaceuticals Announces Private Placement February 13, 2020 9:00 AM - Globe NewsWire Aegon reports second half 2019 results February 13, 2020 1:30 AM - BizWire Aegon reports second half 2019 results February 13, 2020 1:30 AM - BizWire Form SC 13G/A Allergan plc Filed by: VANGUARD GROUP INC February 12, 2020 11:03 AM - SEC Filing Allergen (AGN) PT Raised to $200 at Stifel, Following Earnings February 11, 2020 12:55 PM - StreetInsider Allergen (AGN) PT Raised to $202 at SunTrust February 11, 2020 7:22 AM - StreetInsider Allergen (AGN) PT Raised to $203 at RBC Capital February 10, 2020 11:45 AM - StreetInsider Form SC 13G/A Allergan plc Filed by: BlackRock Inc. February 10, 2020 7:36 AM - SEC Filing Form 8-K Allergan plc For: Feb 10 February 10, 2020 7:25 AM - SEC Filing Allergan (AGN) Tops Q4 EPS by 65c February 10, 2020 7:03 AM - StreetInsider Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results February 10, 2020 7:01 AM - PR NewsWire New drugs contribute to AbbVie's upbeat 2020 view; shares hit year-high February 7, 2020 7:46 AM - StreetInsider Algernon Pharmaceuticals Appoints Professor of Respiratory Medicine Dr. Jacky Smith to Its Medical and Scientific Advisory Board February 7, 2020 6:00 AM - Globe NewsWire Form SC 13G AEGON NV Filed by: BlackRock Inc. February 5, 2020 11:26 AM - SEC Filing BOTOX® Cosmetic (onabotulinumtoxinA) Launches Be The Difference Philanthropic Program February 3, 2020 7:30 AM - PR NewsWire Allergan (AGN) option implied volatility at low end of range January 31, 2020 10:34 AM - StreetInsider Allergan to Report Fourth Quarter and Full Year 2019 Financial Results January 31, 2020 7:30 AM - PR NewsWire Announcement under the Irish Takeover Rules: Relevant Securities in Issue - January 30, 2020 January 30, 2020 4:15 PM - PR NewsWire Form 8-K Allergan plc For: Jan 27 January 27, 2020 8:01 AM - SEC Filing AbbVie (ABBV), Allergan (AGN) Report Agreements to Divest Brazikumab (IL-23 inhibitor) and Zenpep (pancrelipase) January 27, 2020 5:57 AM - StreetInsider Options expected to have increasing volume: AGN WHR KO CPRI HLT MAR January 27, 2020 4:42 AM - StreetInsider AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys January 27, 2020 4:26 AM - StreetInsider AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep January 27, 2020 1:15 AM - PR NewsWire Allergan (AGN) option implied volatility at low end of range into EPS January 24, 2020 10:26 AM - StreetInsider Allergan (AGN) Declares $0.74 Quarterly Dividend; 1.6% Yield January 24, 2020 7:04 AM - StreetInsider Allergan Declares First Quarter 2020 Cash Dividend of $0.74 Per Ordinary Share January 24, 2020 7:00 AM - PR NewsWire Ironwood Pharma (IRWD), Allergan (AGN) Settle LINZESS (linaclotide) Patent Litigation with Teva (TEVA) January 22, 2020 9:21 AM - StreetInsider Ironwood and Allergan Announce Settlement with Teva Resolving LINZESS® (linaclotide) Patent Litigation January 22, 2020 9:20 AM - BizWire Wells Fargo Downgrades Allergen (AGN) to Equal Weight January 22, 2020 4:29 AM - StreetInsider SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results January 17, 2020 7:30 AM - PR NewsWire Algernon Pharmaceuticals Appoints Novotech as CRO for First Phase 2 Trial and Announces Novotech’s $220K Equity Investment January 17, 2020 6:00 AM - Globe NewsWire Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma's Impact on Daily Living January 16, 2020 7:30 AM - PR NewsWire Ironwood Pharma (IRWD), Allergan (AGN) Announce Settlement Resolving LINZESS Patent Litigation January 6, 2020 8:10 AM - StreetInsider Ironwood and Allergan Announce Settlement Resolving LINZESS® (linaclotide) Patent Litigation January 6, 2020 8:00 AM - BizWire Allergan's (AGN) Warner Chilcott and Watson Resolve Antitrust Class Action Litigation January 6, 2020 7:15 AM - StreetInsider Warner Chilcott and Watson Resolve Antitrust Class Action Litigation with Direct and Indirect Purchasers of Loestrin 24 Fe and Minastrin 24 Fe January 6, 2020 7:00 AM - PR NewsWire Form 4 Allergan plc For: Dec 31 Filed by: Swanton Wayne R January 2, 2020 5:58 PM - SEC Filing Form 4 Allergan plc For: Dec 31 Filed by: Nicholson C. David January 2, 2020 5:56 PM - SEC Filing Form 4 Allergan plc For: Dec 31 Filed by: Meury William January 2, 2020 5:54 PM - SEC Filing Form 4 Allergan plc For: Dec 31 Filed by: DArecca James January 2, 2020 5:53 PM - SEC Filing Form 4 Allergan plc For: Dec 31 Filed by: Bailey A Robert D January 2, 2020 5:51 PM - SEC Filing Form 4 Allergan plc For: Dec 31 Filed by: SAUNDERS BRENT L January 2, 2020 5:50 PM - SEC Filing Dealmakers eye cross-border M&A recovery as mega mergers roll on December 31, 2019 9:11 AM - StreetInsider Allergan (AGN) call put ratio 1 call to 9.7 puts with focus on Janary 170 puts December 30, 2019 2:17 PM - StreetInsider Algernon Pharmaceuticals Announces OTC Trading Symbol Change to AGNPF December 30, 2019 6:00 AM - Globe NewsWire Allergan (AGN) Granted FDA Approval for UBRELVY (ubrogepant) December 23, 2019 3:27 PM - StreetInsider Allergan Receives U.S. FDA Approval for UBRELVY™ for the Acute Treatment of Migraine with or without Aura in Adults December 23, 2019 3:13 PM - PR NewsWire Allergan (AGN) receives FDA approval for new treatment for adults with migraine December 23, 2019 2:34 PM - StreetInsider Amgen (AMGN), Allergan (AGN) Submit BLA For ABP 798, Biosimilar Candidate To Rituxan, to FDA December 19, 2019 4:45 PM - StreetInsider Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration December 19, 2019 4:44 PM - PR NewsWire Allergan Foundation Giving Reaches $95 Million Since Inception December 19, 2019 8:37 AM - PR NewsWire Form 6-K AEGON NV For: Dec 19 December 19, 2019 6:51 AM - SEC Filing Aegon reinsures longevity exposure in the Netherlands December 19, 2019 2:00 AM - BizWire Aegon reinsures longevity exposure in the Netherlands December 19, 2019 2:00 AM - BizWire Form 4 Allergan plc For: Dec 12 Filed by: Swanton Wayne R December 16, 2019 2:02 PM - SEC Filing Form 25-NSE AEGON NV Filed by: NEW YORK STOCK EXCHANGE LLC December 16, 2019 9:58 AM - SEC Filing BOTOX® (onabotulinumtoxinA) Celebrates 30 Years of Endless Innovation December 16, 2019 7:00 AM - PR NewsWire Algernon Pharmaceuticals Appoints Leading Respirologist Dr. Martin Kolb to Its Medical and Scientific Advisory Board December 16, 2019 6:00 AM - Globe NewsWire AbbVie (ABBV) and Allergan (AGN) May get U.S. Regulatory Approval in Jan - CNBC December 13, 2019 9:46 AM - StreetInsider Form 6-K AEGON NV For: Dec 12 December 12, 2019 9:00 AM - SEC Filing Aegon: Translating growth opportunities into valuable businesses December 12, 2019 7:00 AM - BizWire Aegon: Translating growth opportunities into valuable businesses December 12, 2019 7:00 AM - BizWire Algernon Pharmaceuticals to Present at 12th Annual LD Micro Main Event Conference on Wednesday December 11, 2019 December 10, 2019 6:00 AM - Globe NewsWire Form 4 Allergan plc For: Dec 06 Filed by: Basgoz Nesli December 9, 2019 4:24 PM - SEC Filing Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110% December 5, 2019 6:00 AM - Globe NewsWire Allergan (AGN) Announces Positive Phase 3 ACHIEVE I Trial Results for Ubrogepant Published in NEJM December 4, 2019 5:29 PM - StreetInsider Allergan Announces Positive Phase 3 ACHIEVE I Trial Results for Ubrogepant Published in The New England Journal of Medicine December 4, 2019 5:26 PM - PR NewsWire AbbVie's (ABBV) Purchase of Allergan (AGN) Gets Chinese Approval - Bloomberg, Citing Website December 3, 2019 7:12 AM - StreetInsider Announcement under the Irish Takeover Rules: Relevant Securities in Issue - November 29, 2019 November 29, 2019 2:00 PM - PR NewsWire National Consumer Rights Law Firm FeganScott Files Second, Expanded Class-Action Lawsuit Against Allergan November 26, 2019 6:06 PM - BizWire Algernon Pharmaceuticals Provides Update on its Planned Phase II Clinical Trial November 25, 2019 7:00 AM - Globe NewsWire Form POSASR AEGON NV November 20, 2019 9:55 AM - SEC Filing Allergan (AGN) Reports Positive Phase 3 ACHIEVE II Trial Results for Ubrogepant Published November 19, 2019 11:24 AM - StreetInsider Allergan Announces Positive Phase 3 ACHIEVE II Trial Results for Ubrogepant Published in The Journal of the American Medical Association November 19, 2019 11:22 AM - PR NewsWire UPDATE: UBS Downgrades Allergen (AGN) to Neutral November 19, 2019 4:41 AM - StreetInsider Allergan® Announces First Annual National BOTOX® Cosmetic (onabotulinumtoxinA) Day November 18, 2019 7:30 AM - PR NewsWire Full Article List